Importance of mitral regurgitation in patients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial.

Saved in:
Bibliographic Details
Title: Importance of mitral regurgitation in patients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial.
Authors: Pellizzon GG (AUTHOR), Grines CL (AUTHOR), Cox DA (AUTHOR), Stuckey T (AUTHOR), Tcheng JE (AUTHOR), Garcia E (AUTHOR), Guagliumi G (AUTHOR), Turco M (AUTHOR), Lansky AJ (AUTHOR), Griffin JJ (AUTHOR), Cohen DJ (AUTHOR), Aymong E (AUTHOR), Mehran R (AUTHOR), O'Neill WW (AUTHOR), Stone GW (AUTHOR)
Source: Journal of the American College of Cardiology (JACC). Apr2004, Vol. 43 Issue 8, p1368-1374. 7p.
Database: Academic Search Ultimate
Description
ISSN:07351097
DOI:10.1016/j.jacc.2003.11.046